First Circuit revives Amphastar suit
A lower court misapplied the Noerr-Pennington doctrine in dismissing antitrust claims that two drugmakers conspired to restrict competition for a generic anticoagulant, the US Court of Appeals for the First Circuit held on Monday.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10